Psilocybin Designated As A “Breakthrough Therapy” For Major Depressive Disorder (MDD) – Collective Evolution

Psilocybin Designated As A “Breakthrough Therapy” For Major Depressive Disorder (MDD) – Collective Evolution: The US Food and Drug Administration (FDA) has recently granted psilocybin treatment (the active component of magic mushrooms) a Breakthrough Therapy classification for the second time this year. They are hoping to accelerate trials that will test its efficacy in treating major depressive disorder (MDD). According to the FDA, a breakthrough therapy designation is for […]